We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

115 hedge funds and large institutions have $211M invested in Accelerate Diagnostics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 24

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

3% more funds holding

Funds holding: 112 → 115 (+3)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

32% less capital invested

Capital invested by funds: $311M → $211M (-$100M)

91% less call options, than puts

Call options by funds: $185K | Put options by funds: $2.15M

Holders
115
Holders Change
+3
Holders Change %
+2.68%
% of All Funds
2.04%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
41
Reduced
24
Closed
13
Calls
$185K
Puts
$2.15M
Net Calls
-$1.96M
Net Calls Change
+$34K

Top Buyers

1
LA
Linden Advisors
New York
+$2.32M
2
Two Sigma Investments
Two Sigma Investments
New York
+$1.55M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.24M
4
CS
Credit Suisse
Switzerland
+$1.02M
5
Renaissance Technologies
Renaissance Technologies
New York
+$973K

Top Sellers

1
ACH
ArrowMark Colorado Holdings
Colorado
-$7.3M
2
AG
Artal Group
Luxembourg
-$4.56M
3
CC
Chicago Capital
Illinois
-$3.21M
4
OIM
Oracle Investment Management
Connecticut
-$2.56M
5
William Blair & Company
William Blair & Company
Illinois
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1.4M -$472K -5,271 -22%
Morgan Stanley
27
Morgan Stanley
New York
$1.21M -$2.13M -23,796 -60%
OCMI
28
Oaktop Capital Management II
New Jersey
$1.18M – – –
Bank of America
29
Bank of America
North Carolina
$1.12M -$39.8K -444 -3%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$1.05M +$1.24M +13,886 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$922K +$851K +9,500 +357%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$909K -$104K -1,157 -9%
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
$885K +$439K +4,900 +72%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$876K +$287K +3,210 +38%
Wells Fargo
35
Wells Fargo
California
$793K +$147K +1,643 +19%
CCM
36
Cadian Capital Management
New York
$678K – – –
Swiss National Bank
37
Swiss National Bank
Switzerland
$520K – – –
CSS
38
Cubist Systematic Strategies
Connecticut
$484K +$96.4K +1,077 +20%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$480K -$11.6K -130 -2%
GCP
40
GSA Capital Partners
United Kingdom
$477K +$564K +6,296 New
TIM
41
Thompson Investment Management
Wisconsin
$462K +$71.6K +800 +15%
TWA
42
TCI Wealth Advisors
Arizona
$421K – – –
PFM
43
Premier Fund Managers
United Kingdom
$375K – – –
Rafferty Asset Management
44
Rafferty Asset Management
New York
$361K +$426K +4,758 New
AllianceBernstein
45
AllianceBernstein
Tennessee
$360K +$23.3K +260 +6%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$355K – – –
OFG
47
Oxford Financial Group
Indiana
$318K – – –
Marshall Wace
48
Marshall Wace
United Kingdom
$314K +$370K +4,136 New
Principal Financial Group
49
Principal Financial Group
Iowa
$309K +$265K +2,962 +264%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$295K +$20.7K +231 +6%
1
2
3 4 5

AXDX Hedge Fund Activity: Q4 2020 in Review

115 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q4 2020, worth a combined $211M — down 32% from $311M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AXDX positions and 13 closed out — a net gain of 4 holders — while 41 added to existing stakes and 24 trimmed.

The largest buyer was Linden Advisors, opening a new position worth an estimated $2.32M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $7.3M sold.

  • 115 institutional investors held Accelerate Diagnostics (AXDX) as of Q4 2020, up from 112 in Q3 2020.
  • Funds reported $211M of Accelerate Diagnostics stock for Q4 2020, down 32% quarter-over-quarter.
  • 17 funds opened new Accelerate Diagnostics positions in Q4 2020 and 13 closed out, a net change of +4 holders.
  • The largest Accelerate Diagnostics buyer in Q4 2020 was Linden Advisors, an estimated $2.32M added.
  • The largest Accelerate Diagnostics seller in Q4 2020 was ArrowMark Colorado Holdings, an estimated $7.3M sold.

Based on aggregated 13F filings for Q4 2020.